老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Taysha Gene Therapies, Inc.

5.79
+0.22504.05%
成交量：139.59萬
成交額：792.17萬
市值：15.85億
市盈率：-17.22
高：5.80
開：5.57
低：5.46
收：5.56
52周最高：5.80
52周最低：1.05
股本：2.74億
流通股本：1.84億
量比：1.01
換手率：0.76%
股息：- -
股息率：- -
每股收益(TTM):-0.3359
每股收益(LYR):-0.3570
淨資產收益率：-64.93%
總資產收益率：-25.70%
市淨率：7.24
市盈率(LYR):-16.20

資料載入中...

總覽公司新聞資訊公告
2020/12/17

重要事件披露

8-K - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/24

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/11/05

重要事件披露

8-K - Current report
2020/11/04

重要事件披露

8-K - Current report
2020/10/27

重要事件披露

8-K - Current report
2020/10/14

重要事件披露

8-K - Current report
2020/10/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/07

重要事件披露

8-K - Current report
2020/10/05

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/05

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/29

重要事件披露

8-K - Current report
2020/09/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/17

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/17

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多